| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $809K | +19.0% |
| SG&A Expense | $807K | -32.1% |
| Interest Expense | $5K | +96.3% |
| Net Income | -$3.9M | -79.6% |
| EPS (Basic) | -$0.25 | -400.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $38 | -99.2% |
| Current Assets | $38 | -99.2% |
| Total Assets | $294 | -94.1% |
| Total Liabilities | $1.1M | +127.7% |
| Stockholders' Equity | -$1.1M | -130.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$199K | +82.9% |
| Financing Cash Flow | $195K | -83.4% |